Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (392)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhu, B. T.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, B. T.
Right arrow Articles by Conney, A. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1-27, Copyright © 1998 by Oxford University Press


REVIEWS

Functional role of estrogen metabolism in target cells: review and perspectives

BT Zhu and AH Conney
Department of Chemical Biology, College of Pharmacy, Rutgers-The State University of New Jersey, Piscataway 08854-8020, USA.

Cytochrome P450 enzymes that metabolize estrogens are expressed in the mammary gland, uterus, brain and other target tissues for estrogen action, and this results in the formation of hydroxylated estrogens in these tissues. Estradiol metabolites formed in target tissues at or near estrogen receptors may either be inactive or have important biological effects, and changes in the activities of estrogen- metabolizing enzymes in target tissues may profoundly influence estrogen action. Although some active estrogen metabolites exert hormonal effects in target tissues by interaction with the classical estrogen receptor, other metabolites appear to elicit unique biological responses that are not associated with activation of this receptor. Therefore, some of the many actions of estradiol may not be caused by estradiol per se, but may result from the formation of active estrogen metabolite(s) which function as local mediators or may activate their own unique receptors or effectors. This is an important area in need of more research. The present paper represents a review of the literature and perspectives by the authors on the functional role of estrogen metabolism in target tissues.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
D. W. Bell, B. W. Brannigan, K. Matsuo, D. M. Finkelstein, R. Sordella, J. Settleman, T. Mitsudomi, and D. A. Haber
Increased Prevalence of EGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms
Clin. Cancer Res., July 1, 2008; 14(13): 4079 - 4084.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Deming, W. Zheng, W.-H. Xu, Q. Cai, Z. Ruan, Y.-B. Xiang, and X.-O. Shu
UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. M. Salih, S. A. Salama, M. Jamaluddin, A. A. Fadl, L. J. Blok, C. W. Burger, M. Nagamani, and A. Al-Hendy
Progesterone-Mediated Regulation of Catechol-O-Methyl Transferase Expression in Endometrial Cancer Cells
Reproductive Sciences, February 1, 2008; 15(2): 210 - 220.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
L. Lehmann, L. Jiang, and J. Wagner
Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells
Carcinogenesis, February 1, 2008; 29(2): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S. Kato, A. Sadarangani, S. Lange, M. Villalon, J. Branes, J. J Brosens, G. I Owen, and M. Cuello
The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium
Endocr. Relat. Cancer, June 1, 2007; 14(2): 351 - 368.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. T. Zhu, G.-Z. Han, J.-Y. Shim, Y. Wen, and X.-R. Jiang
Quantitative Structure-Activity Relationship of Various Endogenous Estrogen Metabolites for Human Estrogen Receptor {alpha} and {beta} Subtypes: Insights into the Structural Determinants Favoring a Differential Subtype Binding
Endocrinology, September 1, 2006; 147(9): 4132 - 4150.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
Y. Wang, K. W. Lee, F. L. Chan, S. Chen, and L. K. Leung
The Red Wine Polyphenol Resveratrol Displays Bilevel Inhibition on Aromatase in Breast Cancer Cells
Toxicol. Sci., July 1, 2006; 92(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Mesia-Vela, R. I. Sanchez, K. R. Reuhl, A. H. Conney, and F. C. Kauffman
Phenobarbital Treatment Inhibits the Formation of Estradiol-Dependent Mammary Tumors in the August-Copenhagen Irish Rat
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 590 - 597.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. King Heiden, M. J. Carvan III, and R. J. Hutz
Inhibition of Follicular Development, Vitellogenesis, and Serum 17{beta}-Estradiol Concentrations in Zebrafish Following Chronic, Sublethal Dietary Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
Toxicol. Sci., April 1, 2006; 90(2): 490 - 499.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. E. Cribb, M. J. Knight, D. Dryer, J. Guernsey, K. Hender, M. Tesch, and T. M. Saleh
Role of polymorphic human cytochrome p450 enzymes in estrone oxidation.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 551 - 558.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. M. Masi, L. C. Hawkley, J. D. Berry, and J. T. Cacioppo
Estrogen Metabolites and Systolic Blood Pressure in a Population-Based Sample of Postmenopausal Women
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1015 - 1020.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-C. E. Lin, S.-C. Chien, P.-C. Hsu, and L.-A. Li
Mechanistic Study of Polychlorinated Biphenyl 126-Induced CYP11B1 and CYP11B2 Up-Regulation
Endocrinology, March 1, 2006; 147(3): 1536 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Tanaka, M. Sasaki, H. Shiina, T. Tokizane, M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro, S. Urakami, et al.
Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Balthazart, M. Baillien, and G. F. Ball
Rapid Control of Brain Aromatase Activity by Glutamatergic Inputs
Endocrinology, January 1, 2006; 147(1): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. M. Weiss, N. S. Weiss, C. M. Ulrich, J. A. Doherty, L. F. Voigt, and C. Chen
Interindividual Variation in Nucleotide Excision Repair Genes and Risk of Endometrial Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2524 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Wellejus, A. Olsen, A. Tjonneland, B. L. Thomsen, K. Overvad, and S. Loft
Urinary Hydroxyestrogens and Breast Cancer Risk among Postmenopausal Women: A Prospective Study
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2137 - 2142.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. R. Starr, C. Chen, D. R. Doody, L. Hsu, S. Ricks, N. S. Weiss, and S. M. Schwartz
Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring Cytochrome P450 Genes Involved in Catechol Estrogen Metabolism
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2183 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. A. Reed, K. S. Peterson, H. J. Smith, J. C. Gray, D. K. Sullivan, M. S. Mayo, J. A. Crowell, and A. Hurwitz
A Phase I Study of Indole-3-Carbinol in Women: Tolerability and Effects
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1953 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Le Marchand, T. Donlon, L. N. Kolonel, B. E. Henderson, and L. R. Wilkens
Estrogen Metabolism-Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1998 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z.-J. Liu, W. J. Lee, and B. T. Zhu
Selective Insensitivity of ZR-75-1 Human Breast Cancer Cells to 2-Methoxyestradiol: Evidence for Type II 17{beta}-Hydroxysteroid Dehydrogenase as the Underlying Cause
Cancer Res., July 1, 2005; 65(13): 5802 - 5811.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C S A Markides and J G Liehr
Specific binding of 4-hydroxyestradiol to mouse uterine protein: evidence of a physiological role for 4-hydroxyestradiol
J. Endocrinol., May 1, 2005; 185(2): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. J. Duell and E. A. Holly
Reproductive and Menstrual Risk Factors for Pancreatic Cancer: A Population-based Study of San Francisco Bay Area Women
Am. J. Epidemiol., April 15, 2005; 161(8): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Kisselev, W.-H. Schunck, I. Roots, and D. Schwarz
Association of CYP1A1 Polymorphisms with Differential Metabolic Activation of 17{beta}-Estradiol and Estrone
Cancer Res., April 1, 2005; 65(7): 2972 - 2978.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Doherty, N. S. Weiss, R. J. Freeman, D. A. Dightman, P. J. Thornton, J. R. Houck, L. F. Voigt, M. A. Rossing, S. M. Schwartz, and C. Chen
Genetic Factors in Catechol Estrogen Metabolism in Relation to the Risk of Endometrial Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Bandiera, S. Weidlich, V. Harth, P. Broede, Y. Ko, and T. Friedberg
Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression
Mol. Pharmacol., February 1, 2005; 67(2): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G.-Z. Han, Z.-J. Liu, K. Shimoi, and B. T. Zhu
Synergism between the Anticancer Actions of 2-Methoxyestradiol and Microtubule-Disrupting Agents in Human Breast Cancer
Cancer Res., January 15, 2005; 65(2): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. K. Dubey, E. K. Jackson, D. G. Gillespie, M. Rosselli, F. Barchiesi, A. Krust, H. Keller, L. C. Zacharia, and B. Imthurn
Cytochromes 1A1/1B1- and Catechol-O-Methyltransferase-Derived Metabolites Mediate Estradiol-Induced Antimitogenesis in Human Cardiac Fibroblast
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. L. CAVALIERI and E. G. ROGAN
A Unifying Mechanism in the Initiation of Cancer and Other Diseases by Catechol Quinones
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 247 - 257.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Ji, C. Aoyama, Y.-D. Nien, P. I. Liu, P. K. Chen, L. Chang, F. Z. Stanczyk, and A. Stolz
Selective Loss of AKR1C1 and AKR1C2 in Breast Cancer and Their Potential Effect on Progesterone Signaling
Cancer Res., October 15, 2004; 64(20): 7610 - 7617.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Lepine, O. Bernard, M. Plante, B. Tetu, G. Pelletier, F. Labrie, A. Belanger, and C. Guillemette
Specificity and Regioselectivity of the Conjugation of Estradiol, Estrone, and Their Catecholestrogen and Methoxyestrogen Metabolites by Human Uridine Diphospho-glucuronosyltransferases Expressed in Endometrium
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5222 - 5232.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z.-H. Chen, Y.-J. Hurh, H.-K. Na, J.-H. Kim, Y.-J. Chun, D.-H. Kim, K.-S. Kang, M.-H. Cho, and Y.-J. Surh
Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells
Carcinogenesis, October 1, 2004; 25(10): 2005 - 2013.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. I. Raeside, H. L. Christie, R. L. Renaud, R. O. Waelchli, and K. J. Betteridge
Estrogen Metabolism in the Equine Conceptus and Endometrium During Early Pregnancy in Relation to Estrogen Concentrations in Yolk-Sac Fluid
Biol Reprod, October 1, 2004; 71(4): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. J. Lee and B. T. Zhu
NADPH-DEPENDENT FORMATION OF POLAR AND NONPOLAR ESTROGEN METABOLITES FOLLOWING INCUBATIONS OF 17{beta}-ESTRADIOL WITH HUMAN LIVER MICROSOMES
Drug Metab. Dispos., August 1, 2004; 32(8): 876 - 883.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, and B. Imthurn
Catecholamines Block the Antimitogenic Effect of Estradiol on Human Coronary Artery Smooth Muscle Cells
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3922 - 3931.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Atkinson, J. W. Lampe, S. S. Tworoger, C. M. Ulrich, D. Bowen, M. L. Irwin, R. S. Schwartz, B. K. Rajan, Y. Yasui, J. D. Potter, et al.
Effects of a Moderate Intensity Exercise Intervention on Estrogen Metabolism in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 868 - 874.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Mizutani, T. Okada, S. Shibutani, E. Sonoda, H. Hochegger, C. Nishigori, Y. Miyachi, S. Takeda, and M. Yamazoe
Extensive Chromosomal Breaks Are Induced by Tamoxifen and Estrogen in DNA Repair-Deficient Cells
Cancer Res., May 1, 2004; 64(9): 3144 - 3147.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. McGrath, S. E. Hankinson, L. Arbeitman, G. A. Colditz, D. J. Hunter, and I. De Vivo
Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility
Carcinogenesis, April 1, 2004; 25(4): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.-L. Eriksson, S. Skrtic, A. Niklason, L. M. Hulten, O. Wiklund, T. Hedner, and C. Ohlsson
Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population
Eur. Heart J., March 1, 2004; 25(5): 386 - 391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson
Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy
Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Duguay, M. McGrath, J. Lepine, J.-F. Gagne, S. E. Hankinson, G. A. Colditz, D. J. Hunter, M. Plante, B. Tetu, A. Belanger, et al.
The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk
Cancer Res., February 1, 2004; 64(3): 1202 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Dubey, S. P. Tofovic, and E. K. Jackson
Cardiovascular Pharmacology of Estradiol Metabolites
J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 403 - 409.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-M. Li, R. Todorovic, P. Devanesan, S. Higginbotham, H. Kofeler, R. Ramanathan, M. L. Gross, E. G. Rogan, and E. L. Cavalieri
Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo
Carcinogenesis, February 1, 2004; 25(2): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J.-Y. Guo, X. Li, J. D. Browning Jr., G. E. Rottinghaus, D. B. Lubahn, A. Constantinou, M. Bennink, and R. S. MacDonald
Dietary Soy Isoflavones and Estrone Protect Ovariectomized ER{alpha}KO and Wild-Type Mice from Carcinogen-Induced Colon Cancer
J. Nutr., January 1, 2004; 134(1): 179 - 182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Wu, C.-C. Tseng, D. Van Den Berg, and M. C. Yu
Tea Intake, COMT Genotype, and Breast Cancer in Asian-American Women
Cancer Res., November 1, 2003; 63(21): 7526 - 7529.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Lee, A. H. Conney, and B. T. Zhu
Human Cytochrome P450 3A7 Has a Distinct High Catalytic Activity for the 16{alpha}-Hydroxylation of Estrone but not 17{beta}-Estradiol
Cancer Res., October 1, 2003; 63(19): 6532 - 6536.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. R. Riley, S. Duensing, T. Brake, K. Munger, P. F. Lambert, and J. M. Arbeit
Dissection of Human Papillomavirus E6 and E7 Function in Transgenic Mouse Models of Cervical Carcinogenesis
Cancer Res., August 15, 2003; 63(16): 4862 - 4871.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Lee, M. X. Cai, P. E. Thomas, A. H. Conney, and B. T. Zhu
Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms
Endocrinology, August 1, 2003; 144(8): 3382 - 3398.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. R. Bianco, G. Perry, M. A. Smith, D. J. Templeton, and M. M. Montano
Functional Implications of Antiestrogen Induction of Quinone Reductase: Inhibition of Estrogen-Induced Deoxyribonucleic Acid Damage
Mol. Endocrinol., July 1, 2003; 17(7): 1344 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. Prokai, K. Prokai-Tatrai, P. Perjesi, A. D. Zharikova, and J. W. Simpkins
QUINOL-BASED METABOLIC CYCLE FOR ESTROGENS IN RAT LIVER MICROSOMES
Drug Metab. Dispos., June 1, 2003; 31(6): 701 - 704.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Samuni, E. Y. Chuang, M. C. Krishna, W. Stein, W. DeGraff, A. Russo, and J. B. Mitchell
Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: Chemoprevention strategies with antioxidants
PNAS, April 29, 2003; 100(9): 5390 - 5395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. P. Torra, C. Duhem, V. Kosykh, J.-C. Fruchart, C. Guillemette, and B. Staels
The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor alpha and gamma Target Gene
J. Biol. Chem., April 11, 2003; 278(16): 13975 - 13983.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. F. Kadlubar, G. S. Berkowitz, R. R. Delongchamp, C. Wang, B. L. Green, G. Tang, J. Lamba, E. Schuetz, and M. S. Wolff
The CYP3A4*1B Variant Is Related to the Onset of Puberty, A Known Risk Factor for the Development of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 327 - 331.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. D. Sibonga, S. Lotinun, G. L. Evans, V. S. Pribluda, S. J. Green, and R. T. Turner
Dose-Response Effects of 2-Methoxyestradiol on Estrogen Target Tissues in the Ovariectomized Rat
Endocrinology, March 1, 2003; 144(3): 785 - 792.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. K. Dubey, D. G. Gillespie, L. C. Zacharia, F. Barchiesi, B. Imthurn, and E. K. Jackson
CYP450- and COMT-Derived Estradiol Metabolites Inhibit Activity of Human Coronary Artery SMCs
Hypertension, March 1, 2003; 41(3): 807 - 813.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
T. H. Rasmussen, T. K. Andreassen, S. N. Pedersen, L. T. M. Van der Ven, P. Bjerregaard, and B. Korsgaard
Effects of waterborne exposure of octylphenol and oestrogen on pregnant viviparous eelpout (Zoarces viviparus) and her embryos in ovario
J. Exp. Biol., December 15, 2002; 205(24): 3857 - 3876.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Lippman and W. K. Hong
Cancer Prevention Science and Practice
Cancer Res., September 15, 2002; 62(18): 5119 - 5125.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Mesia-Vela, R. I. Sanchez, J. J. Li, S. A. Li, A. H. Conney, and F. C. Kauffman
Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited
Carcinogenesis, August 1, 2002; 23(8): 1369 - 1372.